Sun Pharma dividend schedule: Board announces record date for ₹5/share final dividend issue

As per the NSE filing, Sun Pharma’s board of directors have fixed Tuesday, July 7, 2026, as the official record date to determine the eligibility of the shareholders for the financial year ended 2025-26.

“Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tuesday, 07 July 2026 has been fixed as the Record Date for determining the entitlement of shareholders to receive the final dividend of ₹5 per equity share for the financial year 2025-26,” the company informed the stock exchanges.

The final dividend payment of ₹5 per share will be paid to all eligible shareholders who hold the company’s stock up to one day ahead of the record date.

Sun Pharma also disclosed that the dividend payment will be made on or before Friday, August 7, 2026, after the approval in the company’s 34th annual general meeting (AGM) on Friday, July 31, at 4:00 pm (IST).

“Dividend shall be subject to deduction of tax at source at applicable rates,” the company informed its shareholders.

The company will also release its annual report for the fiscal year ended 2025-26 in due course ahead of the company’s upcoming AGM.

How have Sun Pharma shares performed?

Sun Pharma share price closed 0.44% higher at ₹1,794.20 after the trading session on Thursday, compared to ₹1,786.40 at the previous stock market close, according to NSE data. The company announced its record date after the market operating hours on June 11.

Shares of Sun Pharma have delivered more than 164% returns on their investment in the last five years, over 82% gains in the last three years, and more than 6% returns in the past one year period, as per the exchange data.

So far in 2026, the company’s stock has gained 4.5%, but the shares have lost 2.5% in the last one year period. Sun Pharma stocks were trading 0.94% higher in the last five market sessions on NSE.

Shares of Sun Pharma surged to their 52-week high of ₹1,916.60 on May 19, 2026, while the 52-week low was at ₹1,548 on September 26, 2025. The company’s market capitalisation (m-cap) was at over ₹4.31 lakh crore as of the stock market close on Thursday, June 11, 2026.